, 21 tweets, 16 min read Read on Twitter
1/19

Left Main Bifurcation: When & How to Approach?

from the recent @crtmeeting #CRT2019 #CRT2020 #LM #SBKCathLab
2/19

The #LM is oval shaped w/ mean RVD ~ 5mm and mean length ~ 10 mm. The atherosclerotic distribution extends beyond the main shaft to occupy the major side-branches (SB)
3/19

The most prevalent location of disease is the distal LM (70%) w/ extension to the LAD/LCx while the remaining 30% comprise the ostium and the mid-shaft.
4/19

The criteria that determine LM significance are:
1) Angiographic, w/ DS > 70%
2) IVUS imaging, w/ MLA < 6 mm 2 and
3) Physiologic, w/ FFR < 0.80
5/19

Treatment starts by assessing anatomic complexity dictated by Syntax (Sx). In Sx<22, ESC guidelines (GL) ▶️ Class I recommendation for PCI while ACC/AHA GL ▶️ Class II. In intermediate 23<Sx<32 both GL agree for PCI as Class II recommendation.
6/19

In both LM & non-LM BLs, the SB dictates the treatment strategy. Based on the DEFINITION criteria: SB DS & lesion length will dictate whether the LM or non-LM BL is simple or complex (Cx) which will further guide the stenting strategy.
7/19

In non-cx distal LM BLs, 1-stent strategy is preferred. 2 wires for the LAD/LCx w/ mandatory POT as stent diameter is sized based on the distal MB RVD. Kissing balloon inflation (KBI) is not mandatory. Switching from 1- to 2-stent strategy depends on the status of the SB.
8/19

Example of 1-stent strategy in a patient w/ distal LM MEDINA 1,1,0 BL
9/19

In Cx distal LM BL, 2 stents deliver better clinical outcomes long-term. The SB angle dictates the stenting technique. #DKCrush is suitable for every angle leading to significantly longer MACE free outcomes over 3 years. (#CKCrush III)
10/19

#DKCrush Trials are VII thus far. DK I&II proved the superiority of #DKCrush compared to classic crush and provisional stenting (PS) respectively in non-LM CBLs. DK III&V proved the superiority of #DKCrush compared to Culotte & PS respectively in Distal #UPLM BLs.
11/19

#DKCrush V trial was the most recent RCT that was presented as LBCT @TCTConference @TCTMD in 2017
12/19

484 patients w/ Distal #UPLM CBLs MEDINA 1,1,1 & 0,1,1 were randomized 1:1 to either #DKCrush or PS. The primary endpoint was: TLF at 12 months
13/19

TLF within 1 year occurred in 26 patients (10.7%) assigned to PS, and in 12 patients (5.0%) assigned to DK crush (hazard ratio: 0.42; 95% confidence interval: 0.21 to 0.85; p=0.02)
14/19

Compared with PS, #DKCrush also resulted in lower rates of definite or probable stent thrombosis: 3.3% vs. 0.4%; p=0.02
15/19

The distribution of ISR was more prevalent in the ostium of the SB. Nevertheless, #DKCrush showed lower restenotic rate compared to PS in this location.
16/19

The DKCrush III trial compared the culotte stenting technique with the #DKCrush in Distal UPLM CBLs. 419 patients were enrolled and randomly assigned to DK (n=210) or Culotte (n-209). The primary endpoint was MACE @ 1Y
17/19

The cumulative MACE-free survival in the #DKCrush group was significantly greater compared to the Culotte group: 93.8% vs. 83.7%, p=0.001
18/19

Similarly, the components of TLR- & TVR-free survival @ 1Y were significantly greater in the #DKCrush group vs. the Culotte group.
19/19

The #DKCrush technique has been widely accepted worldwide as the "go to" technique for complex distal UPLM CBLs and recently the ESC guidelines insist a Class IIb recommendation w/ level of evidence B for #DKCrush in specific lesion subsets
Missing some Tweet in this thread?
You can try to force a refresh.

Like this thread? Get email updates or save it to PDF!

Subscribe to Bill D. Gogas, MD, PhD
Profile picture

Get real-time email alerts when new unrolls are available from this author!

This content may be removed anytime!

Twitter may remove this content at anytime, convert it as a PDF, save and print for later use!

Try unrolling a thread yourself!

how to unroll video

1) Follow Thread Reader App on Twitter so you can easily mention us!

2) Go to a Twitter thread (series of Tweets by the same owner) and mention us with a keyword "unroll" @threadreaderapp unroll

You can practice here first or read more on our help page!

Follow Us on Twitter!

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just three indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!